Product Identifier Requirements Under the Drug Supply Chain Security Act-Compliance Policy
2016-1234 Product Identifier Requirements Under the Drug Supply Chain Security Act
2017-09-06 2017-09-06 2017-09-06
FDA-2017-D-2232-0009 FDA-2017-D-2232-0017 FDA-2017-D-2232-0020
04:00:00 04:00:00 04:00:00
https://api.regulations.gov/v4/comments/FDA-2017-D-2232-0009 https://api.regulations.gov/v4/comments/FDA-2017-D-2232-0017 https://api.regulations.gov/v4/comments/FDA-2017-D-2232-0020
Anonymous Anonymous Anonymous
Anonymous Anonymous Anonymous
Apotex acknowledges the efforts of the agency on the notice in the Federal Register soliciting public comments on the Draft Guidance for Industry Product Identifier Requirements under the Drug Supply Chain Security Act- Compliance Policy DocketNo- FDA-2017 -D-2232. We appreciate the opportunity to comment on this notice and would like to provide recommendations for your consideration in a separate attachment.  Comments from The Association for Accessible Medicines (AAM) regarding Docket FDA-2017-D-2232: Product Identifier Requirements Under the Drug Supply Chain Security Act-Compliance Policy. On behalf of McKesson, I am pleased to submit comments on the draft guidance for industry, Product Identifier Requirements Under the DSCSA - Compliance Policy.